Kim R. Kampen
Leuven, VLG 3000, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Normoxic HIFα-mediated metabolic rewiring in cancer as a novel therapeutic target of tumor heterogeneity.
Journal: Cancer & metabolism
Published: January 21, 2026
Deficiencies in the Fanconi anemia or homologous recombination pathway enhance the antitumor effects of the hypoxia-activated prodrug CP-506.
Journal: Molecular therapy. Oncology
Published: September 17, 2025
NKX2-1 regulates cell survival, maturation, and DNAdamage responses as a cofactor of RUNX1 in T-cell acute lymphoblastic leukemia.
Journal: Haematologica
Published: April 08, 2025
Reannotation of cancer mutations based on expressed RNA transcripts reveals functional non-coding mutations in melanoma.
Journal: American journal of human genetics
Published: January 02, 2025
Sertraline/chloroquine combination therapy to target hypoxic and immunosuppressive serine/glycine synthesis-dependent glioblastomas.
Journal: Oncogenesis
Published: March 25, 2024
Correction: Targeting serine/glycine metabolism improves radiotherapy response in non-small cell lung cancer.
Journal: British journal of cancer
Published: February 12, 2024
Patient-derived glioblastoma organoids reflect tumor heterogeneity and treatment sensitivity.
Journal: Neuro-oncology advances
Published: December 22, 2023
Targeting serine/glycine metabolism improves radiotherapy response in non-small cell lung cancer.
Journal: British journal of cancer
Published: October 19, 2023
Cancer EV stimulate endothelial glycolysis to fuel protein synthesis via mTOR and AMPKα activation.
Journal: Journal of extracellular vesicles
Published: July 06, 2023
Drivers of de novo Serine/Glycine synthesis in acute leukemia.
Journal: FEBS letters
Published: May 02, 2023
Last Updated: 09/26/2026